Pafolacianine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pafolacianine, covering 2026-02-27 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors [Phase 3]